Literature DB >> 32843387

Chronic mast cell leukaemia with exon 9 KIT mutation A502_Y503dup: a rare imatinib responsive variant.

Sukesh Manthri1, Patrick N Costello2, Koyamangalath Krishnan3.   

Abstract

Entities:  

Keywords:  haematology (incl blood transfusion); oncology; pathology

Mesh：

Substances：

Year:  2020        PMID： 32843387      PMCID： PMC7449486          DOI： 10.1136/bcr-2020-236447

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  5 in total

1.  Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

Authors:  Jason Gotlib; Hanneke C Kluin-Nelemans; Tracy I George; Cem Akin; Karl Sotlar; Olivier Hermine; Farrukh T Awan; Elizabeth Hexner; Michael J Mauro; David W Sternberg; Matthieu Villeneuve; Alice Huntsman Labed; Eric J Stanek; Karin Hartmann; Hans-Peter Horny; Peter Valent; Andreas Reiter
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

2.  Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial.

Authors:  Helga J Droogendijk; Hanneke J C Kluin-Nelemans; Jaap J van Doormaal; Arnold P Oranje; Arjan A van de Loosdrecht; Paul L A van Daele
Journal:  Cancer       Date:  2006-07-15       Impact factor: 6.860

3.  A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.

Authors:  Andrzej Mital; Anna Piskorz; Krzysztof Lewandowski; Bartosz Wasąg; Janusz Limon; Andrzej Hellmann
Journal:  Eur J Haematol       Date:  2011-04-07       Impact factor: 2.997

Review 4.  Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Authors:  P Valent; K Sotlar; W R Sperr; L Escribano; S Yavuz; A Reiter; T I George; H C Kluin-Nelemans; O Hermine; J H Butterfield; H Hägglund; C Ustun; J L Hornick; M Triggiani; D Radia; C Akin; K Hartmann; J Gotlib; L B Schwartz; S Verstovsek; A Orfao; D D Metcalfe; M Arock; H-P Horny
Journal:  Ann Oncol       Date:  2014-03-27       Impact factor: 32.976

Review 5.  Chronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical features.

Authors:  Peter Valent; Karl Sotlar; Wolfgang R Sperr; Andreas Reiter; Michel Arock; Hans-Peter Horny
Journal:  Leuk Res       Date:  2014-09-30       Impact factor: 3.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.